We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Mirum Pharmaceuticals Inc | NASDAQ:MIRM | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.87 | -3.36% | 25.04 | 24.00 | 24.95 | 25.92 | 24.82 | 25.86 | 357,020 | 21:08:13 |
|
Delaware
|
001-38981
|
83-1281555
|
(State or Other Jurisdiction
of Incorporation) |
(Commission File Number)
|
(IRS Employer
Identification No.) |
950 Tower Lane
Suite 1050
|
||
Foster City, California
|
94404
|
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
Title of each class |
Trading
Symbol(s) |
Name of each exchange on which registered |
||
Common stock, par value $0.0001 per share
|
MIRM
|
Nasdaq Global Market
|
Exhibit
No.
|
Description
|
|
|
||
104 |
Cover Page Interactive Data File (embedded within the Inline XBRL document) |
Mirum Pharmaceuticals, Inc.
|
||
Date: May 5, 2022
|
By:
|
/s/ Christopher Peetz
|
Christopher Peetz
|
||
President and Chief Executive Officer
|
1 Year Mirum Pharmaceuticals Chart |
1 Month Mirum Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions